Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Camostat Mesylate”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT04353284
What this trial is testing

Camostat Mesylate in COVID-19 Outpatients

Who this might be right for
COVID-19
Yale University 70
Testing effectiveness (Phase 2)Study completedNCT04524663
What this trial is testing

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Who this might be right for
Covid19
Stanford University 49
Testing effectiveness (Phase 2)Looking for participantsNCT06794593
What this trial is testing

Effect Camostat for Kidney Protection in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease(CKD)
Odense University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT04435015
What this trial is testing

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

Who this might be right for
CoagulopathyCardiovascular ComplicationCOVID-19
Yale University
Testing effectiveness (Phase 2)Study completedNCT04470544
What this trial is testing

Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome
Alan Bryce 100
Testing effectiveness (Phase 2)Study completedNCT04681430
What this trial is testing

Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals

Who this might be right for
Corona Virus InfectionSARS-CoV-2 InfectionSARS-CoV-2 PCR Test Positive+1 more
Heinrich-Heine University, Duesseldorf 22
Testing effectiveness (Phase 2)Ended earlyNCT04750759
What this trial is testing

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat

Who this might be right for
Covid19
Charité Research Organisation GmbH 4
Testing effectiveness (Phase 2)Study completedNCT04321096
What this trial is testing

The Impact of Camostat Mesilate on COVID-19 Infection

Who this might be right for
Corona Virus Infection
University of Aarhus 206
Testing effectiveness (Phase 2)Ended earlyNCT04625114
What this trial is testing

The Potential of Camostat in COVID-19

Who this might be right for
Covid19
University Hospital, Ghent 108
Early research (Phase 1)Ended earlyNCT04652765
What this trial is testing

Camostat With Bicalutamide for COVID-19

Who this might be right for
Covid19SARS-CoV InfectionCoronavirus Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Testing effectiveness (Phase 2)Ended earlyNCT04455815
What this trial is testing

A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)

Who this might be right for
COVID-19 Infection
Cancer Research UK 34
Early research (Phase 1)Study completedNCT04782505
What this trial is testing

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 61
Testing effectiveness (Phase 2)Study completedNCT05474664
What this trial is testing

Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation

Who this might be right for
Fontan OperationProtein-Losing EnteropathyCamostat Mesylate
Seoul National University Hospital 19
Large-scale testing (Phase 3)UnknownNCT04355052
What this trial is testing

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus

Who this might be right for
COVID - 19
Sheba Medical Center 250
Testing effectiveness (Phase 2)Ended earlyNCT04530617
What this trial is testing

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Who this might be right for
Covid19DiabetesHypertension+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 246
Post-approval studies (Phase 4)WithdrawnNCT04338906
What this trial is testing

Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19

Who this might be right for
COVID
Heinrich-Heine University, Duesseldorf
Testing effectiveness (Phase 2)Ended earlyNCT04662073
What this trial is testing

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol

Who this might be right for
Covid19
Stanford University 2
Large-scale testing (Phase 3)Ended earlyNCT04608266
What this trial is testing

CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients

Who this might be right for
Covid19
Assistance Publique - Hôpitaux de Paris 70
Testing effectiveness (Phase 2)Study completedNCT04583592
What this trial is testing

Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)

Who this might be right for
COVID-19
Sagent Pharmaceuticals Inc. 295
Early research (Phase 1)Study completedNCT04644705
What this trial is testing

Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat

Who this might be right for
Healthy Volunteers
Charité Research Organisation GmbH 28